Skip to main content
. 2022 Dec 2;83(6):694–701. doi: 10.1055/a-1963-7511

Table 3 Decrease of left ventricular ejection fraction under therapy with ABP 980 compared with reference trastuzumab (RTZ).

ABP 980 RTZ total P value*
* chi-squared-test; LVEF = left ventricular ejection fraction; RTZ = reference trastuzumab
LVEF 0.279

  • Stable

 43 (93.5) 76 (97.4) 119 (95.9)

  • Decrease > 10%

 5 (6.5) 2 (2.6) 5 (4.1)